Sage Therapeutics Investor Relations Material
Latest events
M&A Announcement
Sage Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sage Therapeutics Inc
Access all reports
Sage Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of treatments for central nervous system (CNS) disorders. Its research targets psychiatric, neurological, and neurodevelopmental conditions. The company operates across the drug discovery, clinical development, and commercialization stages, aiming to address unmet medical needs in brain health. Sage Therapeutics Inc is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Sage Therapeutics Inc
Q4 2024
Sage Therapeutics Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Sage Therapeutics Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
SAGE
Country
🇺🇸 United States